| 000 | 01046 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514180606.0 | ||
| 264 | 0 | _c20040426 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a1389-2010 | ||
| 024 | 7 |
_a10.2174/1389201043489657 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchroecksnadel, K | |
| 245 | 0 | 0 |
_aModerate hyperhomocysteinemia and immune activation. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical biotechnology _cFeb 2004 |
||
| 300 |
_a107-18 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperhomocysteinemia _ximmunology |
| 650 | 0 | 4 |
_aTh1 Cells _ximmunology |
| 650 | 0 | 4 |
_aVitamin B 12 Deficiency _ximmunology |
| 700 | 1 | _aFrick, B | |
| 700 | 1 | _aWirleitner, B | |
| 700 | 1 | _aWinkler, C | |
| 700 | 1 | _aSchennach, H | |
| 700 | 1 | _aFuchs, D | |
| 773 | 0 |
_tCurrent pharmaceutical biotechnology _gvol. 5 _gno. 1 _gp. 107-18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1389201043489657 _zAvailable from publisher's website |
| 999 |
_c14687816 _d14687816 |
||